186 related articles for article (PubMed ID: 12651267)
1. The factor V (FV) gene ASP79HIS polymorphism modulates FV plasma levels and affects the activated protein C resistance phenotype in presence of the FV Leiden mutation.
Bossone A; Cappucci F; D'Andrea G; Brancaccio V; Cibelli G; Iannaccone L; Grandone E; Margaglione M
Haematologica; 2003 Mar; 88(3):286-9. PubMed ID: 12651267
[TBL] [Abstract][Full Text] [Related]
2. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM
Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
[TBL] [Abstract][Full Text] [Related]
3. Primary thrombophilia in Mexico IV: frequency of the Leiden, Cambridge, Hong Kong, Liverpool and HR2 haplotype polymorphisms in the factor V gene of a group of thrombophilic Mexican Mestizo patients.
Ruiz-Argüelles GJ; Poblete-Naredo I; Reyes-Núñez V; Garcés-Eisele J; López-Martínez B; Gómez-Rangel JD
Rev Invest Clin; 2004; 56(5):600-4. PubMed ID: 15776863
[TBL] [Abstract][Full Text] [Related]
4. A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 Haplotype) polymorphisms.
Bouaziz-Borgi L; Nguyen P; Hezard N; Musharrafieh U; Almawi WY; Mahjoub T
Exp Mol Pathol; 2007 Dec; 83(3):480-3. PubMed ID: 17555744
[TBL] [Abstract][Full Text] [Related]
5. Intraindividual consistency of the activated protein C resistance phenotype.
Tosetto A; Simioni M; Madeo D; Rodeghiero F
Br J Haematol; 2004 Aug; 126(3):405-9. PubMed ID: 15257714
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of activated protein C resistance phenotype in subjects with compound heterozygosity for HR2 haplotype and FV Leiden mutation (R506Q) in factor V gene.
Castaman G; Ruggeri M; Tosetto A; Rodeghiero F
Thromb Haemost; 2000 Aug; 84(2):357-8. PubMed ID: 10959717
[No Abstract] [Full Text] [Related]
7. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance.
Guasch JF; Lensen RP; Bertina RM
Thromb Haemost; 1997 Feb; 77(2):252-7. PubMed ID: 9157576
[TBL] [Abstract][Full Text] [Related]
8. Factor V Leiden mutation in one family of Chinese origin.
Wu J; Gu J; Xu J; Wang J; Sun Z; Smirnov MD; Morrissey JH; Esmon N
Chin Med J (Engl); 2001 Apr; 114(4):379-81. PubMed ID: 11780458
[TBL] [Abstract][Full Text] [Related]
9. The frequency of factor V Leiden and concomitance of factor V Leiden with prothrombin G20210A mutation and methylene tetrahydrofolate reductase C677T gene mutation in healthy population of Denizli, Aegean region of Turkey.
Kabukcu S; Keskin N; Keskin A; Atalay E
Clin Appl Thromb Hemost; 2007 Apr; 13(2):166-71. PubMed ID: 17456626
[TBL] [Abstract][Full Text] [Related]
10. The VITA Project: heritability of resistance to activated protein C. Vincenza Thrombophilia and Arteriosclerosis.
Tosetto A; Castaman G; Cappellari A; Rodeghiero F
Thromb Haemost; 2000 Nov; 84(5):811-4. PubMed ID: 11127861
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of phenotype resistance to activated protein C (APC resistance)].
Hudecek J; Ivanková J; Dobrotová M; Hybenová J; Pullmann R; Kubisz P
Vnitr Lek; 1999 Dec; 45(12):723-8. PubMed ID: 10951849
[TBL] [Abstract][Full Text] [Related]
12. A missense mutation (Y1702C) in the coagulation factor V gene is a frequent cause of factor V deficiency in the Italian population.
Castoldi E; Lunghi B; Mingozzi F; Muleo G; Redaelli R; Mariani G; Bernardi F
Haematologica; 2001 Jun; 86(6):629-33. PubMed ID: 11418372
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic APC resistance as a marker of hypercoagulability in primitive cerebral lymphoma.
De Lucia D; De Francesco F; Marotta R; Maisto G; Meo D; Sessa M; Misso M; Galante M; Russo T; Pignalosa O; Napolitano M; Papa ML; Niglio A; Di Micco P
Exp Oncol; 2005 Jun; 27(2):159-61. PubMed ID: 15995637
[TBL] [Abstract][Full Text] [Related]
14. Factor V HR2 haplotype: a risk factor for venous thromboembolism in individuals with absence of Factor V Leiden.
Otrock ZK; Taher AT; Shamseddeen WA; Zaatari G; Bazarbachi A; Mahfouz RA
Ann Hematol; 2008 Dec; 87(12):1013-6. PubMed ID: 18654780
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of three reactants for the detection of activated protein C resistance due to mutation of factor V Leiden during pregnancy].
Magdelaine A; Soubrier F; Berkane N; Uzan S; Verdy E
Ann Biol Clin (Paris); 1998; 56(4):445-50. PubMed ID: 9754280
[TBL] [Abstract][Full Text] [Related]
16. Rescue of activated protein C-resistance phenotype by cis-acting factor V Gly2032Asp mutation.
Asselta R; Bossone A; Iannaccone L; Duga S; Brancaccio V; Margaglione M
Haematologica; 2004 Jun; 89(6):761-2. PubMed ID: 15194551
[TBL] [Abstract][Full Text] [Related]
17. Coagulation factor V G allele and HR2 haplotype: factor V activity, activated protein C resistance and risk of venous thrombosis.
Kostka H; Schwarz T; Schellong S; Mix C; Kuhlisch E; Temelkova-Kurktschiev T; Henkel E; Köhler C; Gehrisch S; Siegert G
Blood Coagul Fibrinolysis; 2003 Jan; 14(1):49-56. PubMed ID: 12544728
[TBL] [Abstract][Full Text] [Related]
18. The factor V gene A4070G mutation and the risk of venous thrombosis.
Alhenc-Gelas M; Nicaud V; Gandrille S; van Dreden P; Amiral J; Aubry ML; Fiessinger JN; Emmerich J; Aiach M
Thromb Haemost; 1999 Feb; 81(2):193-7. PubMed ID: 10063990
[TBL] [Abstract][Full Text] [Related]
19. Association of factor V gene polymorphisms (Leiden; Cambridge; Hong Kong and HR2 haplotype) with recurrent idiopathic pregnancy loss in Tunisia. A case-control study.
Zammiti W; Mtiraoui N; Mercier E; Abboud N; Saidi S; Mahjoub T; Almawi WY; Gris JC
Thromb Haemost; 2006 Apr; 95(4):612-7. PubMed ID: 16601830
[TBL] [Abstract][Full Text] [Related]
20. FV HR2 haplotype as additional inherited risk factor for deep vein thrombosis in individuals with a high-risk profile.
Margaglione M; Bossone A; Coalizzo D; D'Andrea G; Brancaccio V; Ciampa A; Grandone E; Di MG
Thromb Haemost; 2002 Jan; 87(1):32-6. PubMed ID: 11848454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
